-Reuters
Morgan Stanley Maintains Equal-Weight on Moderna, Lowers Price Target to $313
Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $337 to $313.
Related Posts
Vacasa Q2 2021 Gross Booking Value $514M
Vacasa's Operating and Financial Results Exceed Targets. Second quarter 2021 Gross Booking Value, Revenue, and Adjusted EBITDA all finished above the targets outlined in the Investor Presentation filed
Northland Capital Markets Initiates Coverage On Andina Acquisition with Outperform Rating, Announces Price Target of $15
Northland Capital Markets analyst Mike Grondahl initiates coverage on Andina Acquisition (NASDAQ:ANDA) with a Outperform rating and announces Price Target of $15.
Hot Doge! Order Doge-Themed Food at New Dubai Restaurant, Pay In Various Cryptos
A new online-only restaurant launched in Dubai offers a take on the meme cryptocurrency Dogecoin (CRYPTO: DOGE) with themed food items, packaging and the ability for users to pay for orders with cryptocurrency.